Brief news reports on Tuberculosis

Not as simple as thought: How bacteria form membrane vesicles

Tsukuba, Japan - Bacteria have the ability to form membrane vesicles to communicate with each other, but also to defend themselves against antibiotics. In a new study, researchers from the University of Tsukuba discovered a novel mechanism by which mycolic acid-containing bacteria, a specific group of bacteria with a special type of cell membrane, form membrane vesicles.

Read More →

Virtual symposium: TB Preventive Therapy as Emergency Response to COVID-19

The Sentinel Project on Pediatric Drug-Resistant Tuberculosis and partners will host a virtual symposium, TB Preventive Therapy as Emergency Response to COVID-19, on 27 January 2021.

Read More →

Tuberculosis kills as many people each year as COVID-19. It’s time we found a better vaccine

In July 1921, a French infant became the first person to receive an experimental vaccine against tuberculosis (TB), after the mother had died from the disease. The vaccine, known as Bacille Calmette-Guérin (BCG), is the same one still used today.

Read More →

Global roadmap for research and development for TB vaccines

The Amsterdam Institute for Global Health and Development published the Global roadmap for research and development for TB vaccines as a draft document for public consultation, developed with key stakeholders. 

Read More →

Tuberculosis in Ireland — a lesson from history

THE Covid-19 crisis is not the very first time that contagious disease has existed and lessons can be learned from how the Irish government got to grips with a tuberculosis crisis in 1940s Ireland.

Read More →

December 2020 issue of Public Health Action now online

Public Health Action is the free access, online journal of The International Union Against Tuberculosis and Lung Disease. The journal focuses on TB, lung health, non-communicable diseases and related public health issues.

Read More →

Cost-effectiveness of scaling up short course preventive therapy for TB among children across 12 countries

A study published in EClinicalMedicine assessed the cost-effectiveness of household contact investigation for TB treatment and short-course preventive therapy provision for children under 15 years old across 12 high TB burden countries.

Read More →

Public call: Update of the WHO high-priority target product profiles for TB diagnostics

The World Health Organization (WHO) is initiating a public comment process for partners and stakeholders to provide inputs on the updated high-priority target product profiles for next-generation drug-susceptibility testing at peripheral centers.

Read More →

Resist the resistance: Fighting the good fight against bacteria

UNIVERSITY PARK, Pa. — Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust. In an effort to reduce the potential infection-caused 10 million deaths worldwide, Penn State researcher Scott Medina has developed a peptide, or small protein, that can target a specific pathogen without damaging the good bacteria that bolsters the immune system. 

Read More →

To make sense of COVID, look at TB

I felt fear for the first time during this pandemic. I was speaking to a man who was on maximum oxygen, one step away from being on a ventilator. I told him that if he went on a ventilator, he would likely be on it for weeks, with an uncertain outcome. Did he want a ventilator if it came to that? He seemed visibly anxious. I held his hand and felt his fear. At that time, I should have acknowledged it. I should have reassured him by saying that caring for critically ill patients was our specialty. That he was receiving the best care anyone could receive. But I didn’t. I remained frozen at that moment because I was scared. What would I do if I were in his situation? How terrifying would it be to be in an ugly ICU room by myself?

Read More →

Page 2 of 736 · Total posts: 10

←First 1 2 3 Last→